In Silico #002

​Recent advancements in computation are transforming the biomolecular sciences - from fine simulations of molecular structure and drug discovery, to coarse-grained systems analysis of complex biochemical, metabolic, or genetic networks. We can now accomplish in days what once took large teams of chemists and biologists months to design.

​Join us to discuss the future of biology and drug development with flash talks from:

• ​Sebastian Schmon (Latent Labs) - Latent-X: An Atom-level Frontier Model for De Novo Protein Binder Design

• ​Amy Lu (UC Berkeley) - Repurposing Protein Folding Models for All-Atom Generation via Latent Space Compression

• ​Dominik Dekleva (AstraZeneca) - Synthesis-Aware Molecular Generation with REINVENT

• ​Simon Mathis (Cambridge) - Accelerating Biomolecular Modeling with AtomWorks and RF3

​Sponsors

​Supported by Renaissance Philanthropy - a nonprofit dedicated to sparking a 21st-century renaissance by elevating the ambitions of philanthropists, scientists, and innovators.

​​Powered by ​The Advanced Research + Invention Agency (ARIA), a UK R&D funding agency built to unlock scientific and technological breakthroughs that benefit everyone. ARIA empowers scientists and engineers, from their Programme Directors to the teams they fund, with the resources and freedom to pursue breakthroughs at the edge of the possible.

​Supported by IDEALondon